TY  - GEN
AU  - Kiesslich,Tobias
AU  - Neureiter,Daniel
TI  - HDAC inhibitors in liver cancer: which route to take?
SN  - 1747-4132
PY  - 2019///1213
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Carcinoma, Hepatocellular
KW  - drug therapy
KW  - Clinical Decision-Making
KW  - Disease Progression
KW  - Epigenesis, Genetic
KW  - drug effects
KW  - Histone Deacetylase Inhibitors
KW  - Humans
KW  - Liver Neoplasms
KW  - Patient Selection
KW  - Treatment Outcome
N1  - Publication Type: Editorial
UR  - https://doi.org/10.1080/17474124.2019.1605289
ER  -